Alimera Sciences Inc (STU:ASZ1)
€ 2.865 0.03 (1.06%) Market Cap: 152.26 Mil Enterprise Value: 203.15 Mil PE Ratio: 0 PB Ratio: 4.07 GF Score: 59/100

Alimera Sciences Inc Annual Shareholders Meeting Transcript

Jun 18, 2019 / 01:30PM GMT
Release Date Price: €12.04 (-0.82%)
Richard S. Eiswirth
Alimera Sciences, Inc. - President, CEO & Director

Welcome to the 2019 Annual Meeting of the Stockholders of Alimera Sciences, Inc. It is now 9:30 a.m. Eastern, and the meeting will please come to order.

My name is Rick Eiswirth, and as Chief Executive Officer, I will preside over the meeting. I would like to introduce our other directors who are present today through our virtual meeting: Garheng Kong, Jim Largent, Dan Myers and Peter Pizzo. Also present are Dr. Samer Kaba, our Chief Medical Officer; Philip Ashman, our Chief Operating Officer; Phil Jones, our Chief Financial Officer; Dave Holland, our Chief Marketing Officer; Chris Visick, our General Counsel and Secretary; Lou Larsen, who will act as inspector of elections for this meeting; and Joseph Heatherly from Grant Thornton LLP, the company's independent public accountants.

We have adopted an agenda for our program this morning. In accordance with the agenda, we will proceed as follows: First, I will conduct the official business of the 2019 Annual Meeting. During this portion of the meeting, all

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot